Integral Diagnostics Ltd (AU:IDX) — Market Cap & Net Worth

$585.79 Million USD · AU$827.90 Million AUD · Rank #11748

Market Cap & Net Worth: Integral Diagnostics Ltd (IDX)

Integral Diagnostics Ltd (AU:IDX) has a market capitalization of $585.79 Million (AU$827.90 Million) as of May 2, 2026. Listed on the AU stock exchange, this Australia-based company holds position #11748 globally and #294 in its home market, demonstrating a 0.91% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Integral Diagnostics Ltd's stock price AU$2.22 by its total outstanding shares 372926663 (372.93 Million). Analyse Integral Diagnostics Ltd (IDX) cash conversion ratio to see how efficiently the company converts income to cash.

Integral Diagnostics Ltd Market Cap History: 2015 to 2026

Integral Diagnostics Ltd's market capitalization history from 2015 to 2026. Data shows growth from $325.80 Million to $585.79 Million (4.72% CAGR).

Index Memberships

Integral Diagnostics Ltd is a constituent of 3 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Australia All Ordinaries AORD	$1.97 Trillion	0.03%	#216 of 495
S&P/ASX 300 AXKO	$2.13 Trillion	0.03%	#214 of 300
ASX Small Ordinaries AXSO	$294.63 Billion	0.20%	#122 of 200

Weight: Integral Diagnostics Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Integral Diagnostics Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Integral Diagnostics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

1.07x

Integral Diagnostics Ltd's market cap is 1.07 times its annual revenue

Industry average: 2.24x Lower than industry average

Latest Price to Earnings (P/E) Ratio

143.43x

Integral Diagnostics Ltd's market cap is 143.43 times its annual earnings

Industry average: 211.96x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$244.98 Million	$167.77 Million	$11.39 Million	1.46x	21.51x
2017	$490.35 Million	$179.73 Million	$15.48 Million	2.73x	31.68x
2018	$607.16 Million	$189.40 Million	$15.08 Million	3.21x	40.27x
2019	$885.33 Million	$232.39 Million	$20.98 Million	3.81x	42.19x
2020	$1.03 Billion	$274.08 Million	$23.03 Million	3.76x	44.71x
2021	$1.20 Billion	$348.81 Million	$31.27 Million	3.45x	38.51x
2022	$740.02 Million	$358.74 Million	$14.60 Million	2.06x	50.68x
2023	$491.14 Million	$440.10 Million	$25.04 Million	1.12x	19.61x
2024	$767.86 Million	$469.70 Million	-$60.70 Million	1.63x	N/A
2025	$670.23 Million	$627.22 Million	$4.67 Million	1.07x	143.43x

Competitor Companies of IDX by Market Capitalization

Companies near Integral Diagnostics Ltd in the global market cap rankings as of May 2, 2026.

Key companies related to Integral Diagnostics Ltd by market ranking:

Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#126	Thermo Fisher Scientific Inc	NYSE:TMO	$176.29 Billion	$469.21
#189	Danaher Corporation	NYSE:DHR	$123.72 Billion	$175.15
#578	IDEXX Laboratories Inc	NASDAQ:IDXX	$45.31 Billion	$567.46
#643	LONZA GROUP UNSP.ADR 1/10	F:LO3A	$41.04 Billion	€54.50

Integral Diagnostics Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Integral Diagnostics Ltd's market cap moved from $325.80 Million to $ 585.79 Million, with a yearly change of 4.72%.

Year	Market Cap	Change (%)
2026	AU$585.79 Million	-12.60%
2025	AU$670.23 Million	-12.71%
2024	AU$767.86 Million	+56.34%
2023	AU$491.14 Million	-33.63%
2022	AU$740.02 Million	-38.55%
2021	AU$1.20 Billion	+16.94%
2020	AU$1.03 Billion	+16.32%
2019	AU$885.33 Million	+45.81%
2018	AU$607.16 Million	+23.82%
2017	AU$490.35 Million	+100.16%
2016	AU$244.98 Million	-24.81%
2015	AU$325.80 Million	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Integral Diagnostics Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$585.79 Million USD
MoneyControl	$585.79 Million USD
MarketWatch	$585.79 Million USD
marketcap.company	$585.79 Million USD
Reuters	$585.79 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research

Market Cap

$585.79 Million

AU$827.90 Million AUD

Market Cap Rank

#11748 Global

#294 in Australia

Share Price

AU$2.22

Change (1 day)

-0.45%

52-Week Range

AU$2.19 - AU$3.05

All Time High

AU$5.00